Drug-induced liver injury in cancer patients-Reference-Cited by-同舟云学术

Drug-induced liver injury in cancer patients

Published:2020-10-16 Issue:3 Volume:15 Page:80-94
ISSN:2413-4023
Container-title:Oncohematology
language:
Short-container-title:Onkogematologiâ

Author:

Ivashkin V. T.¹^ORCID,Raikhelson K. L.²^ORCID,Palgova L. K.²^ORCID,Maevskaya M. V.¹^ORCID,Gerasimova O. A.³^ORCID,Kondrashina E. A.²^ORCID,Marchenko N. V.³^ORCID,Baranovsky A. Yu.²^ORCID

Affiliation:

1. I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)

2. Saint-Petersburg State University

3. Saint-Petersburg State University; Russian Research Center for Radiology and Surgical Technologies named after acad. A. M. Granov, Ministry of Health of Russia

Abstract

This review includes information about epidemiological data, development feature, phenotypes, principles of classification, diagnosis, and prognosis for drug-induced liver injury (DILI). Actual clinical recommendations regarding management of the DILI arising in the chemotherapy of cancer discussed. Drugs that can influence on individual pathogenetic mechanisms of growth and symptoms DILI are considered. Clinical studies for the prophylaxis and treatment of DILI associated with anticancer chemotherapy analyzed in detail. The prevention and treatment regimens for DILI in patients receiving chemotherapy and immunotherapy various localizations of cancer given both in research and in practical recommendations.

Publisher

Publishing House ABV Press

Subject

Oncology,Hematology

Reference54 articles.

1. Larionova V.B., Gromova E.G., Snegovoy A.V. Clinical guidelines for the correction of hepatotoxicity induced by antitumor chemotherapy. M., 2014. Available at: http://www.oncology.ru/association/clinical-guidelines/2014/09.pdf. (In Russ.).

2. Bahirwani R., Reddy K.R. Drug-induced liver injury due to cancer chemotherapeutic agents. Semin Liver Dis 2014;34(2):162–71. DOI: 10.1055/s-0034-1375957.

3. Azad A., Chang P., Devuni D. et al. Real world experience of drug induced liver injury in patients undergoing chemotherapy. J Clin Gastroenterol Hepatol 2018;2(3):18. DOI: 10.21767/2575-7733.1000047.

4. Andrade R.J., Aithal G.P., Björnsson E.S. et al. EASL clinical practice guidelines: drug-induced liver injury. J Hepatol 2019;70(6):1222–61. DOI: 10.1016/j.jhep.2019.02.014.

5. Chalasani N.P., Hayashi P.H., Bonkovsky H.L. et al. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am J Gastroenterol 2014;109(7):950–66. DOI: 10.1038/ajg.2014.131.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research of subchronic oral toxicity after the injection of organotin compounds containing a fragment of 2,6-di-tert-butylphenol;South Russian Journal of Therapeutic Practice;2023-06-06